Compare AUR & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AUR | PEN |
|---|---|---|
| Founded | 2017 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.5B | 12.6B |
| IPO Year | 2021 | 2015 |
| Metric | AUR | PEN |
|---|---|---|
| Price | $6.31 | $325.26 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 16 |
| Target Price | $9.43 | ★ $360.14 |
| AVG Volume (30 Days) | ★ 27.8M | 283.2K |
| Earning Date | 05-06-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 4.35 | ★ 1155.56 |
| EPS | N/A | ★ 1.70 |
| Revenue | $3,000,000.00 | ★ $1,403,665,000.00 |
| Revenue This Year | $407.30 | $14.34 |
| Revenue Next Year | $1,134.58 | $13.71 |
| P/E Ratio | ★ N/A | $190.45 |
| Revenue Growth | N/A | ★ 17.50 |
| 52 Week Low | $3.60 | $221.26 |
| 52 Week High | $8.57 | $362.41 |
| Indicator | AUR | PEN |
|---|---|---|
| Relative Strength Index (RSI) | 44.55 | 56.22 |
| Support Level | $5.78 | $315.31 |
| Resistance Level | $6.75 | $329.67 |
| Average True Range (ATR) | 0.35 | 2.03 |
| MACD | -0.08 | -0.15 |
| Stochastic Oscillator | 24.06 | 52.41 |
Aurora Innovation is a US autonomous driving provider for heavy trucks. The company produces and sells its Aurora Driver system, which includes hardware installed in a vehicle, software to autonomously drive it, and data management to maintain and improve the software. Aurora targets long-haul routes. The company currently offers its trucking-as-a-service model, where it owns and operates the trucks and makes deliveries for customers. The company plans to start selling its driver-as-a-service model next year, where fleet owners will own the trucks and Aurora's software will operate them.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.